BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16102374)

  • 1. Examining the influence of drop-outs in a follow-up of maintained opiate users.
    Encrenaz G; Rondeau V; Messiah A; Auriacombe M
    Drug Alcohol Depend; 2005 Sep; 79(3):303-10. PubMed ID: 16102374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs.
    Fitzmaurice GM; Laird NM; Shneyer L
    Stat Med; 2001 Apr; 20(7):1009-21. PubMed ID: 11276032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial.
    Bell JR; Ryan A; Mutch C; Batey R; Rea F
    Drug Alcohol Depend; 2008 Jul; 96(1-2):183-6. PubMed ID: 18423901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity analysis of longitudinal normal data with drop-outs.
    Minini P; Chavance M
    Stat Med; 2004 Apr; 23(7):1039-54. PubMed ID: 15057877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frequency and causes of premature termination (drop-out) during in-patient opiate detoxification].
    Gössling HW; Gunkel S; Schneider U; Melles W
    Fortschr Neurol Psychiatr; 2001 Oct; 69(10):474-81. PubMed ID: 11602924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial.
    Robertson JR; Raab GM; Bruce M; McKenzie JS; Storkey HR; Salter A
    Addiction; 2006 Dec; 101(12):1752-9. PubMed ID: 17156174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Descriptive studies of the use of the Addiction Severity Index in France].
    Martin C; Grabot D; Auriacombe M; Brisseau S; Daulouède JP; Tignol J
    Encephale; 1996; 22(5):359-63. PubMed ID: 9035992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the outcome of methadone maintenance treatment in opiate dependence.
    Kamal F; Flavin S; Campbell F; Behan C; Fagan J; Smyth R
    Ir Med J; 2007 Mar; 100(3):393-7. PubMed ID: 17491538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random.
    Preisser JS; Lohman KK; Rathouz PJ
    Stat Med; 2002 Oct; 21(20):3035-54. PubMed ID: 12369080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three estimators of the probability of opiate use from incomplete data.
    Gross AJ
    NIDA Res Monogr; 1992; 128():82-94; discussion 95-6. PubMed ID: 1436018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.